Crop Life Science Limited (NSE:CLSL)
India · Delayed Price · Currency is INR 44.00
0.00 (0.00%)
Jun 16, 2026, 1:20 PM IST
Crop Life Science Revenue
In the fiscal year ending March 31, 2026, Crop Life Science had annual revenue of 2.07B INR with 3.28% growth. Crop Life Science had revenue of 869.02M in the half year ending March 31, 2026, a decrease of -14.10%.
Revenue
2.07B
Revenue Growth
+3.28%
P/S Ratio
0.36
Revenue / Employee
9.87M
Employees
210
Market Cap
754.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.07B | 65.84M | 3.28% |
| Mar 31, 2025 | 2.01B | 19.79M | 1.00% |
| Mar 31, 2024 | 1.99B | 673.85M | 51.35% |
| Mar 31, 2023 | 1.31B | 292.16M | 28.64% |
| Mar 31, 2022 | 1.02B | -169.20M | -14.23% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rajgor Castor Derivatives | 8.72B |
| TBI Corn | 3.05B |
| ShreeOswal Seeds and Chemicals | 2.48B |
| Dollex Agrotech | 2.25B |
| Baba Food Processing (India) | 2.05B |
| Nirman Agri Genetics | 1.97B |
| Agro Phos (India) | 1.48B |
| Upsurge Seeds Of Agriculture | 1.33B |